Olaf Henriksen

1.4k total citations
30 papers, 1.1k citations indexed

About

Olaf Henriksen is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Olaf Henriksen has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Olaf Henriksen's work include Epilepsy research and treatment (22 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Neuroscience and Neuropharmacology Research (7 papers). Olaf Henriksen is often cited by papers focused on Epilepsy research and treatment (22 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Neuroscience and Neuropharmacology Research (7 papers). Olaf Henriksen collaborates with scholars based in Norway, Sweden and Denmark. Olaf Henriksen's co-authors include Svein I. Johannessen, Rezaul Karim, R. Reife, Gordon Pledger, Helge Bjørnæs, Y Løyning, Elinor Ben‐Menachem, Isak Gath, Lynn D. Kramer and Marianne Mikkelsen and has published in prestigious journals such as Neurology, Epilepsia and Electroencephalography and Clinical Neurophysiology.

In The Last Decade

Olaf Henriksen

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Henriksen Norway 16 756 607 323 173 87 30 1.1k
H. Stefan Germany 15 581 0.8× 374 0.6× 276 0.9× 176 1.0× 128 1.5× 63 907
Athanasios Covanis Greece 20 1.2k 1.6× 830 1.4× 448 1.4× 250 1.4× 126 1.4× 30 1.6k
R. Sankar United States 18 693 0.9× 530 0.9× 348 1.1× 144 0.8× 205 2.4× 40 1.3k
Paul A. Hwang Canada 20 640 0.8× 495 0.8× 364 1.1× 108 0.6× 214 2.5× 40 1.2k
Rajesh Sachdeo United States 14 976 1.3× 818 1.3× 471 1.5× 102 0.6× 196 2.3× 24 1.6k
David G. Vossler United States 22 970 1.3× 632 1.0× 446 1.4× 175 1.0× 91 1.0× 61 1.2k
Kenou van Rijckevorsel Belgium 18 737 1.0× 450 0.7× 352 1.1× 262 1.5× 83 1.0× 45 1.1k
Masakazu Seino Japan 17 651 0.9× 384 0.6× 362 1.1× 140 0.8× 117 1.3× 98 839
Martin Prevett United Kingdom 16 632 0.8× 424 0.7× 307 1.0× 135 0.8× 124 1.4× 25 1.1k
Charlotte B. McCutchen United States 13 1.0k 1.4× 860 1.4× 354 1.1× 224 1.3× 72 0.8× 19 1.3k

Countries citing papers authored by Olaf Henriksen

Since Specialization
Citations

This map shows the geographic impact of Olaf Henriksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Henriksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Henriksen more than expected).

Fields of papers citing papers by Olaf Henriksen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Henriksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Henriksen. The network helps show where Olaf Henriksen may publish in the future.

Co-authorship network of co-authors of Olaf Henriksen

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Henriksen. A scholar is included among the top collaborators of Olaf Henriksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Henriksen. Olaf Henriksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakken, Karl O., Olaf Henriksen, Geir Ketil Røste, & Rasmus Lossius. (2002). Vagal nerve stimulation—the Norwegian experience. Seizure. 12(1). 37–41. 24 indexed citations
3.
Pålhagen, Sven, et al.. (2001). Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy. Epilepsy Research. 43(2). 115–124. 109 indexed citations
4.
Henriksen, Olaf, et al.. (2001). [Chronic intermittent vagal nerve stimulation--a new therapeutic approach in epilepsy].. PubMed. 121(13). 1582–5. 1 indexed citations
5.
Brodtkorb, Eylert, Trond Oskar Aamo, Olaf Henriksen, & Rasmus Lossius. (1999). Rectal diazepam: pitfalls of excessive use in refractory epilepsy. Epilepsy Research. 35(2). 123–133. 5 indexed citations
6.
Trenité, Dorothée Kasteleijn‐Nolst, C.D. Binnie, G. F. A. Harding, et al.. (1999). Photic stimulation — standardization of screening methods. Neurophysiologie Clinique. 29(4). 318–324. 39 indexed citations
7.
Brodtkorb, Eylert, Andersen Kv, Olaf Henriksen, Gunnar Myhr, & Kari Skullerud. (1998). Focal, continuous spikes suggest cortical developmental abnormalities Clinical, MRI and neuropathological correlates. Acta Neurologica Scandinavica. 98(6). 377–385. 16 indexed citations
8.
Thoresen, Marianne, et al.. (1997). Does a sedative dose of chloral hydrate modify the EEG of children with epilepsy?. Electroencephalography and Clinical Neurophysiology. 102(2). 152–157. 41 indexed citations
9.
Tassinari, C. A., Roberto Michelucci, Patrick Chauvel, et al.. (1996). Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy. Epilepsia. 37(8). 763–768. 159 indexed citations
10.
Ben‐Menachem, Elinor, Olaf Henriksen, Mogens Dam, et al.. (1996). Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures. Epilepsia. 37(6). 539–543. 206 indexed citations
11.
Tassinari, C. A., Patrick Chauvel, Jan Chodkiewicz, et al.. (1995). DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 600 MG/DAY TOPIRAMATE AS ADD-ON THERAPY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY. UCL Discovery (University College London). 10 indexed citations
12.
Henriksen, Olaf. (1994). What is needed from a neurological point of view?. Acta Neurologica Scandinavica. 89(S152). 190–191. 2 indexed citations
13.
Dreifuss, Fritz E. & Olaf Henriksen. (1992). Classification of epileptic seizures and the epilepsies. Acta Neurologica Scandinavica. 86(S140). 8–17. 6 indexed citations
14.
Henriksen, Olaf. (1990). Education and Epilepsy: Assessment and Remediation. Epilepsia. 31(s4). S21–5. 23 indexed citations
15.
Henriksen, Olaf. (1988). Specific Problems of Children with Epilepsy. Epilepsia. 29(s3). S6–9. 12 indexed citations
16.
Henriksen, Olaf & Svein I. Johannessen. (1984). Valproate Monotherapy. Epilepsia. 25(s1). S73–7. 7 indexed citations
17.
Karlsen, R. Lund, K Kett, & Olaf Henriksen. (1983). Intoxication with Sodium Valproate. Acta Medica Scandinavica. 213(5). 405–406. 17 indexed citations
18.
Blichert-Toft, M, et al.. (1979). Treatment of mastalgia with bromocriptine: a double-blind cross-over study.. BMJ. 1(6158). 237.1–237. 33 indexed citations
19.
Johannessen, Svein I. & Olaf Henriksen. (1979). Comparative steady state serum levels of valproic acid administered as two different formulations - Deprakine® and Orfiril®. Acta Neurologica Scandinavica. 60(6). 371–374. 2 indexed citations
20.
Henriksen, Olaf, M. Nasser Kotby, & A Kayan. (1971). Auditory evoked responses The basis for a promising objective audiometric test. The Journal of Laryngology & Otology. 85(3). 233–242. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026